Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Due from related party
Deferred offering costs
Current assets
Cash
Cash and cash equivalents
Inventory - current
Prepaid expenses
Accounts receivable
Supplier advances
Other receivables
Total current assets
Cash held in Trust Account
Investments held in Trust Account
Long-term inventory
Property, plant, and equipment, net
Operating lease right-of-use asset
Intangible asset, net
Deposits
Total assets
Accrued offering costs
Promissory note - related party
Current liabilities
Accounts payable
Accrued expenses
Promissory note - related party
Non redemptions agreement liabilities
Non-redemption agreements liabilities
Accrued underwriting commission
Deferred underwriting commission
Seller note payable - current
Operating lease liabilities - current
Other payables
Short term convertible notes
Short term debt
Related party payables - current
Total current liabilities
Deferred underwriting commissions
Forward purchase options liabilities
Forward purchase options liabilities
Deferred underwriting fee payable
Non-current liabilities
Accrual for contingent liabilities
Operating lease liabilities, net of current
Related party payables
Total liabilities
Class A ordinary shares subject to possible redemption, $0.0001 par value; 2,119,553 and 4,642,030 shares issued and outstanding at redemption value of approximately $10.54 and $10.16 per share as of September 30, 2023 and December 31, 2022, respectively
Class A Ordinary Shares
Total class A ordinary shares subject to possible redemption, $0.0001 par value; 2,119,553 and 4,642,030 shares issued and outstanding at redemption value of approximately $10.54 and $10.16 per share as of September 30, 2023 and December 31, 2022, respectively
Shareholders' deficit:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of September 30, 2023 and December 31, 2022
Common stock; par value $0.0001, 300,000,000 shares authorized, 57,866,830 issued and outstanding at March 31, 2024 and December 31, 2023; Common stock; par value $0.0001, 70,000,000 shares authorized; Preferred stock 50,000,000 shares authorized, 0 issued and outstanding at March 31, 2024 and December 31, 2023
Class A Ordinary Shares
Class B Ordinary Shares
Total common stock; par value $0.0001, 300,000,000 shares authorized, 57,866,830 issued and outstanding at March 31, 2024 and December 31, 2023; Common stock; par value $0.0001, 70,000,000 shares authorized; Preferred stock 50,000,000 shares authorized, 0 issued and outstanding at March 31, 2024 and December 31, 2023
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,666,667 and 6,666,667 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively
Additional paid-in-capital
Accumulated deficit
Accumulated other comprehensive loss
Class A Ordinary Shares
Class B Ordinary Shares
Total shareholders' deficit
Total liabilities and shareholders' deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support